MYC and neuroblastoma: Nevertheless, our results are limited to targets of MYCN and c-MYC during development, and we have thus not addressed the relevance of other post-natal sympathoadrenal cell populations and/or molecular mechanisms resulting in poor outcome in NB (i.e., cell response to DNA damage, DNA repair, RNA splicing, and cell movement) [68].